NEOSTIGMINE METHYLSULFATE au Canada
26 fiches de médicaments provenant de 11 titulaires portent ce nom dans les sources officielles. Collectées le 16 novembre 2026.
Médicaments
| Nom | Titulaire | Statut | Code |
|---|---|---|---|
| NEOSTIGMINE METHYLSULFATE INJ 0.5MG/ML USP · .5 MG per ML · LIQUID | DAVID BULL LABORATORIES (PTY) LTD. | cancelled |
DIN
01904183Code de médicament DPD
12251
|
| NEOSTIGMINE METHYLSULFATE INJ 1MG/ML USP · 1 MG per ML · LIQUID | DAVID BULL LABORATORIES (PTY) LTD. | cancelled |
DIN
01914588Code de médicament DPD
11913
|
| NEOSTIGMINE METHYLSULFATE INJECTION · 0.5 MG per ML · LIQUID | FRESENIUS KABI CANADA LTD | cancelled |
DIN
02243104Code de médicament DPD
66971
|
| NEOSTIGMINE METHYLSULFATE INJECTION · 1 MG per ML · LIQUID | FRESENIUS KABI CANADA LTD | cancelled |
DIN
02243103Code de médicament DPD
66970
|
| NEOSTIGMINE METHYLSULFATE INJECTION SDZ · 0.5 MG per ML · SOLUTION | SANDOZ CANADA INCORPORATED | cancelled |
DIN
02385201Code de médicament DPD
87085
|
| NEOSTIGMINE METHYLSULFATE INJECTION SDZ · 2.5 MG per ML · SOLUTION | SANDOZ CANADA INCORPORATED | cancelled |
DIN
02385228Code de médicament DPD
87086
|
| NEOSTIGMINE METHYLSULFATE INJECTION USP · 0.5 MG per ML · SOLUTION | SANDOZ CANADA INCORPORATED | cancelled |
DIN
00874957Code de médicament DPD
11095
|
| NEOSTIGMINE METHYLSULFATE INJECTION USP · 0.5 MG per ML · SOLUTION | MARCAN PHARMACEUTICALS INC | authorised |
DIN
02475480Code de médicament DPD
96586
|
| NEOSTIGMINE METHYLSULFATE INJECTION USP · 0.5 MG per ML · SOLUTION | STERIMAX INC | authorised |
DIN
02497778Code de médicament DPD
98757
|
| NEOSTIGMINE METHYLSULFATE INJECTION, USP · 0.5 MG per ML · SOLUTION | JAMP PHARMA CORPORATION | authorised |
DIN
02537516Code de médicament DPD
102622
|
| NEOSTIGMINE METHYLSULFATE INJECTION, USP · 0.5 MG per ML · SOLUTION | JUNO PHARMACEUTICALS CORP. | cancelled |
DIN
02546175Code de médicament DPD
103489
|
| NEOSTIGMINE METHYLSULFATE INJECTION USP · 1 MG per ML · LIQUID | SANDOZ CANADA INCORPORATED | cancelled |
DIN
00885282Code de médicament DPD
11131
|
| NEOSTIGMINE METHYLSULFATE INJECTION USP · 1 MG per ML · SOLUTION | MARCAN PHARMACEUTICALS INC | authorised |
DIN
02475499Code de médicament DPD
96587
|
| NEOSTIGMINE METHYLSULFATE INJECTION USP · 1 MG per ML · SOLUTION | STERIMAX INC | authorised |
DIN
02497786Code de médicament DPD
98758
|
| NEOSTIGMINE METHYLSULFATE INJECTION, USP · 1 MG per ML · SOLUTION | JUNO PHARMACEUTICALS CORP. | cancelled |
DIN
02546183Code de médicament DPD
103490
|
| NEOSTIGMINE METHYLSULFATE INJECTION USP · 2.5 MG per ML · SOLUTION | SANDOZ CANADA INCORPORATED | cancelled |
DIN
01915436Code de médicament DPD
11852
|
| NEOSTIGMINE METHYLSULFATE INJECTION, USP · 2.5 MG per ML · SOLUTION | JUNO PHARMACEUTICALS CORP. | cancelled |
DIN
02546191Code de médicament DPD
103491
|
| NEOSTIGMINE OMEGA · 0.5 MG per ML · LIQUID | OMEGA LABORATORIES LIMITED | authorised |
DIN
02230593Code de médicament DPD
49702
|
| NEOSTIGMINE OMEGA · 1 MG per ML · LIQUID | OMEGA LABORATORIES LIMITED | authorised |
DIN
02230592Code de médicament DPD
49701
|
| NEOSTIGMINE OMEGA · 2.5 MG per ML · SOLUTION | OMEGA LABORATORIES LIMITED | authorised |
DIN
02387166Code de médicament DPD
87274
|
| PMS-NEOSTIGMINE METHYLSULFATE INJ 0.5MG/ML · .5 MG per ML · LIQUID | PHARMASCIENCE INC | cancelled |
DIN
00868906Code de médicament DPD
10876
|
| PMS-NEOSTIGMINE METHYLSULFATE INJ 1MG/ML · 1 MG per ML · LIQUID | PHARMASCIENCE INC | cancelled |
DIN
00868930Code de médicament DPD
10877
|
| PROSTIGMIN INJ 1:1000 USP · 1 MG per ML · LIQUID | ICN CANADA LTD. | cancelled |
DIN
00869929Code de médicament DPD
12162
|
| PROSTIGMIN INJ 1:2000 USP · .5 MG per ML · LIQUID | ICN CANADA LTD. | cancelled |
DIN
00869910Code de médicament DPD
12161
|
| PROSTIGMIN INJ 1:400 USP · 2.5 MG per ML · SOLUTION | ICN CANADA LTD. | cancelled |
DIN
00869937Code de médicament DPD
12163
|
| STIMULINE INJ 2MG/ML · 2 MG per ML · LIQUID | DISTRIVET INC. | cancelled |
DIN
00564508Code de médicament DPD
5753
|
Besoin de cette liste dans votre propre système ?
Chaque fiche de cette page est disponible via l’API, avec sa source, sa licence et sa date de collecte.